Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (37)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Lux, A.
Right arrow Articles by Marchuk, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lux, A.
Right arrow Articles by Marchuk, D. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2000, Vol. 9, No. 5 745-755
© 2000 Oxford University Press

Expression analysis of endoglin missense and truncation mutations: insights into protein structure and disease mechanisms

Andreas Lux, Carol J. Gallione and Douglas A. Marchuk+

Department of Genetics, Duke University Medical Center, Box 3175, Durham, NC 27710, USA

Hereditary hemorrhagic telangiectasia (HHT) is an inherited autosomal dominant vascular dysplasia caused by mutations in either endoglin (HHT1) or activin-like kinase receptor-1 (ALK-1) (HHT2). The majority of the mutations in endoglin cause frameshifts and premature stop codons. Although initial reports suggested a dominant-negative model for HHT1, more recent reports have suggested that mutations in endoglin lead to haploinsufficiency. In this study, we investigated six different missense mutations and two truncation mutations in the endoglin gene to examine whether mechanisms other than haploinsufficiency might be involved in HHT1. Expression of the missense mutants alone revealed that they are misfolded and that most show no cell surface expression. When co-expressed with wild-type endoglin, the missense mutants are able to dimerize with the normal endoglin protein and are trafficked to the cell surface. We also show that although one truncation mutation acts through haploinsufficiency, the other acts in a dominant-negative way. This implies that either dominant-negative protein interactions or haploinsufficiency can cause HHT1. The biochemical analyses for the different mutations suggest that the endoglin N-terminus is important for correct protein folding and that cysteine residues in the first 350 amino acids are involved in intramolecular disulfide bonds, whereas cysteines located closer to the C-terminus of the extracellular domain are responsible for inter­molecular disulfide bond dimerization.

+ To whom correspondence should be addressed. Tel: +1 919 684 3290; Fax: +1 919 681 9193; Email: march004@mc.duke.edu


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
Q. Meng, A. Lux, A. Holloschi, J. Li, J. M. X. Hughes, T. Foerg, J. E. G. McCarthy, A. M. Heagerty, P. Kioschis, M. Hafner, et al.
Identification of Tctex2beta, a Novel Dynein Light Chain Family Member That Interacts with Different Transforming Growth Factor-beta Receptors
J. Biol. Chem., December 1, 2006; 281(48): 37069 - 37080.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. I. Koleva, B. A. Conley, D. Romero, K. S. Riley, J. A. Marto, A. Lux, and C. P. H. Vary
Endoglin Structure and Function: DETERMINANTS OF ENDOGLIN PHOSPHORYLATION BY TRANSFORMING GROWTH FACTOR-beta RECEPTORS
J. Biol. Chem., September 1, 2006; 281(35): 25110 - 25123.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
P. Roll, G. Rudolf, S. Pereira, B. Royer, I. E. Scheffer, A. Massacrier, M.-P. Valenti, N. Roeckel-Trevisiol, S. Jamali, C. Beclin, et al.
SRPX2 mutations in disorders of language cortex and cognition
Hum. Mol. Genet., April 1, 2006; 15(7): 1195 - 1207.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
C.-J. Jeng, Y.-T. Chen, Y.-W. Chen, and C.-Y. Tang
Dominant-negative effects of human P/Q-type Ca2+ channel mutations associated with episodic ataxia type 2
Am J Physiol Cell Physiol, April 1, 2006; 290(4): C1209 - C1220.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Lux, C. Beil, M. Majety, S. Barron, C. J. Gallione, H.-M. Kuhn, J. N. Berg, P. Kioschis, D. A. Marchuk, and M. Hafner
Human Retroviral gag- and gag-pol-like Proteins Interact with the Transforming Growth Factor-{beta} Receptor Activin Receptor-like Kinase 1
J. Biol. Chem., March 4, 2005; 280(9): 8482 - 8493.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. K. Meurer, L. Tihaa, B. Lahme, A. M. Gressner, and R. Weiskirchen
Identification of Endoglin in Rat Hepatic Stellate Cells: NEW INSIGHTS INTO TRANSFORMING GROWTH FACTOR {beta} RECEPTOR SIGNALING
J. Biol. Chem., January 28, 2005; 280(4): 3078 - 3087.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
F. Sanz-Rodriguez, M. Guerrero-Esteo, L.-M. Botella, D. Banville, C. P. H. Vary, and C. Bernabeu
Endoglin Regulates Cytoskeletal Organization through Binding to ZRP-1, a Member of the Lim Family of Proteins
J. Biol. Chem., July 30, 2004; 279(31): 32858 - 32868.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. A. Conley, R. Koleva, J. D. Smith, D. Kacer, D. Zhang, C. Bernabeu, and C. P. H. Vary
Endoglin Controls Cell Migration and Composition of Focal Adhesions: FUNCTION OF THE CYTOSOLIC DOMAIN
J. Biol. Chem., June 25, 2004; 279(26): 27440 - 27449.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
S Naz, F Alasti, A Mowjoodi, S Riazuddin, M H Sanati, T B Friedman, A J Griffith, E R Wilcox, and S Riazuddin
Distinctive audiometric profile associated with DFNB21 alleles of TECTA
J. Med. Genet., May 1, 2003; 40(5): 360 - 363.
[Full Text] [PDF]

Home page
 Hum Mol GenetHome page
D. A. Marchuk, S. Srinivasan, T. L. Squire, and J. S. Zawistowski
Vascular morphogenesis: tales of two syndromes
Hum. Mol. Genet., April 2, 2003; 12(90001): R97 - 112.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
S. van den Driesche, C. L. Mummery, and C. J.J. Westermann
Hereditary hemorrhagic telangiectasia: an update on transforming growth factor {beta} signaling in vasculogenesis and angiogenesis
Cardiovasc Res, April 1, 2003; 58(1): 20 - 31.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
C. L. Wellington, Y.-Z. Yang, S. Zhou, S. M. Clee, B. Tan, K. Hirano, K. Zwarts, A. Kwok, A. Gelfer, M. Marcil, et al.
Truncation mutations in ABCA1 suppress normal upregulation of full-length ABCA1 by 9-cis-retinoic acid and 22-R-hydroxycholesterol
J. Lipid Res., November 1, 2002; 43(11): 1939 - 1949.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
J. L. Wiggs and D. Vollrath
Molecular and Clinical Evaluation of a Patient Hemizygous for TIGR/MYOC
Arch Ophthalmol, November 1, 2001; 119(11): 1674 - 1678.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
M.-E. Paquet, N. Pece-Barbara, S. Vera, U. Cymerman, A. Karabegovic, C. Shovlin, and M. Letarte
Analysis of several endoglin mutants reveals no endogenous mature or secreted protein capable of interfering with normal endoglin function
Hum. Mol. Genet., June 1, 2001; 10(13): 1347 - 1357.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.